This track will explore the latest advancements in functional genomics and their applications in drug discovery and development. Researchers will present novel methodologies and findings that enhance our understanding of drug mechanisms and efficacy.

This session will focus on the development and application of therapeutic antibodies and cancer vaccines in oncology. Discussions will include recent breakthroughs and challenges in the clinical translation of these biotherapeutics.

This track will delve into the role of nanotechnology in the creation of innovative cancer therapies. Presentations will cover the design and efficacy of nanocarriers, including stealth nanoparticles and tumor-penetrating peptides.

This session will analyze the global market for anticancer drugs, focusing on their economic impact and cost-effectiveness. Researchers will discuss pricing strategies, accessibility, and the implications for healthcare systems.

This track will highlight cutting-edge drug delivery systems designed for cancer treatment. Emphasis will be placed on novel formulations and technologies that improve therapeutic outcomes and minimize side effects.

This session will investigate the complex interactions within the cancer microenvironment and their implications for tumor progression and therapy response. Researchers will present findings on how the microenvironment influences drug efficacy.

This track will cover recent developments in chemotherapy drugs, including new agents and combination therapies. Presentations will focus on mechanisms of action, resistance, and clinical outcomes.

This session will explore the interactions between vectors and hosts in the context of cancer biology. Discussions will include the implications of these interactions for therapeutic strategies and disease progression.

This track will focus on the latest advancements in early diagnosis and imaging techniques for cancer detection. Researchers will present innovative approaches that enhance diagnostic accuracy and patient outcomes.

This session will discuss the identification and validation of novel cancer biomarkers. Presentations will highlight their potential uses in early detection, prognosis, and personalized treatment strategies.

This track will emphasize the importance of integrative approaches in cancer research, combining genomics, proteomics, and metabolomics. Researchers will present interdisciplinary studies that provide comprehensive insights into cancer biology.